| 1. |
Weaver TE, Sawyer A. Management of obstructive sleep apnea by continuous positive airway pressure. Oral Maxillofac Surg Clin North Am, 2009, 21(4): 403-412.
|
| 2. |
李蘭鳳, 劉維英, 楊婷婷, 等. 還原型谷胱甘肽對間歇低氧大鼠下丘腦-垂體-腎上腺軸超微結構及功能的干預作用. 中華結核和呼吸雜志, 2015, 38(2): 138-140.0.
|
| 3. |
Assoumou HG, Gaspoz JM, Sforza E, et al. Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort. Sleep Breath, 2012, 16(3): 895-902.
|
| 4. |
Botros N, Concato J, Mohsenin V, et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med, 2009, 122(12): 1122-1127.
|
| 5. |
Shpirer I, Rapoport MJ, Stav D, et al. Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath, 2012, 16(2): 461-466.
|
| 6. |
Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes, 2010, 17(2): 161-165.
|
| 7. |
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest, 2014, 146(5): 1387-1394.
|
| 8. |
Bjorvatn B, Pallesen S, Gronli J, et al. Prevalence and correlates of insomnia and excessive sleepiness in adults with obstructive sleep apnea symptoms. Percept Mot Skills, 2014, 118(2): 571-586.
|
| 9. |
林其昌, 黃建釵, 丁海波, 等. 福州市 20 歲以上人群阻塞性睡眠呼吸暫停低通氣綜合征流行病學調查. 中華結核和呼吸雜志, 2009, 32(3): 193-197.0.
|
| 10. |
Iseki K, Tohyama K, Matsumoto T, et al. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res, 2008, 31(2): 249-255.
|
| 11. |
Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis, 1987, 10(6): 470-472.
|
| 12. |
Tang X, Xu F, Chen DM, et al. The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults. Clin Nephrol, 2013, 80(2): 130-139.
|
| 13. |
Lyons OD, Chan CT, Yadollahi A, et al. Effect of ultrafiltration on sleep apnea and sleep structure in patients with end-stage renal disease. Am J Respir Crit Care Med, 2015, 191(11): 1287-1294.
|
| 14. |
劉維英, 余勤. 低氧誘導因子-1 在阻塞性睡眠呼吸暫停低通氣綜合征病理機制研究進展.中華結核和呼吸雜志, 2013, 36(5): 370-3720.
|
| 15. |
Tang R, Yang C, Tao JL, et al. Epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells induced by urinary proteins requires the activation of PKC-alpha and betaI isozymes. Cell Biol Int, 2011, 35(9): 953-959.
|
| 16. |
Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens, 2001, 19(12): 2271-2277.
|
| 17. |
de Abreu-Silva EO, Beltrami-Moreira M. Sleep apnea: an underestimated cause of resistant hypertension. Curr Hypertens Rev, 2014, 10(1): 2-7.
|
| 18. |
Prabhakar NR, Kumar GK, Peng YJ. Sympatho-adrenal activation by chronic intermittent hypoxia. J Appl Physiol (1985), 2012, 113(8): 1304-1310.
|
| 19. |
Foster GE, Hanly PJ, Ahmed SB, et al. Intermittent hypoxia increases arterial blood pressure in humans through a Renin-Angiotensin system-dependent mechanism. Hypertension, 2010, 56(3): 369-377.
|
| 20. |
Namtvedt SK, Hisdal J, Randby A, et al. Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart, 2013, 99(1): 30-34.
|
| 21. |
Alonso-Fernandez A, Garcia-Rio F, Arias MA, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax, 2009, 64(7): 581-586.
|
| 22. |
米熱古麗?阿不都熱合曼, 買爾旦?阿布來. 阻塞型睡眠呼吸暫停低通氣綜合征患者腎素、血管緊張素水平的研究. 吉林醫學, 2014, (36): 8011-8012.0.
|
| 23. |
Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J Geriatr Cardiol, 2016, 13(4): 333-343.
|
| 24. |
Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens, 2012, 26(5): 281-287.
|
| 25. |
閆曉娟, 趙欣, 李希平, 等. 阻塞性睡眠呼吸暫停低通氣綜合征對腎素和醛固酮的影響. 中國醫刊, 2016, 51(5): 30-32.0.
|
| 26. |
李婷, 李秀翠, 梁冬施, 等. 慢性間歇性低氧對大鼠腎臟氧化應激損傷及 HIF-1α 表達的影響. 中國病理生理雜志, 2015, 31(2): 348-353.0.
|
| 27. |
Westhoff M, Litterst P. [Obstructive sleep apnoea and oxidative stress]. Pneumologie, 2012, 66(10): 610-615.
|
| 28. |
Baysal E, Taysi S, Aksoy N, et al. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Eur Rev Med Pharmacol Sci, 2012, 16(6): 770-774.
|
| 29. |
Ntalapascha M, Makris D, Kyparos A, et al. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath, 2013, 17(2): 549-555.
|
| 30. |
Yamauchi M, Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal, 2008, 10(4): 755-768.
|
| 31. |
da Rosa DP, Forgiarini LF, Baronio D, et al. Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediators Inflamm, 2012, 2012: 879419.
|
| 32. |
Li L, Wang ZW, Li J, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace, 2014, 16(9): 1309-1314.
|
| 33. |
吳艷艷. 反復覺醒對心血管系統的影響: 探究 OSAHS 患者心血管并發癥的發生機制[D]. 北京協和醫學院, 2013.
|
| 34. |
黎嬌. 氧化應激和交感神經活性在阻塞性睡眠呼吸暫停低通氣綜合征合并高血壓發病機制中的作用[D]. 南昌大學醫學院, 2015.
|
| 35. |
Fu Y, Xia Y, Yi H, et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath, 2016, :.
|
| 36. |
Puckrin R, Iqbal S, Zidulka A, et al. Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea. Int Urol Nephrol, 2015, 47(11): 1839-1845.
|
| 37. |
Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc, 1994, 94(11): 1291-1295.
|
1/5
WeChat